Mobilizing Stakeholders to Drive ICD Reimbursement
Sudden cardiac arrhythmia (SCA) is the #1 killer in the U.S., yet implantable cardioverter- defibrillators (ICDs) were under-utilized and perceived negatively due to cost. Early signals indicated CMS may not reimburse ICDs despite strong clinical evidence. To influence the CMS decision, GCI Health established the SCA Alliance – comprised of representatives from 18 patient and professional organizations – to demonstrate broad support for ICDs. The result was a decision by CMS to reimburse 85% of at-risk patients, and 95% of media coverage from the program focused on ICD value, not cost.